New Visual Test Detects Glaucoma Earlier Than Current Care

Newswise — Denver, Colo. – Shifting detection to even earlier than currently used tests, scientists have used vection to identify mild glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Patients with mild glaucoma were found to have weaker responses to vection – a sensation of self-motion that depends on peripheral vision – than people with healthy vision. Better early detection could reduce the amount of vision loss patient’s experience.

Glaucoma is a debilitating eye disease that gradually diminishes eyesight, starting with peripheral vision. Early detection remains difficult because physical damage to the eyes tends to occur before any differences in vision are noticed.

Abstract Title: Effects of early glaucoma on vection responsesPresentation Start/End Time: Sunday, May 3, 3:15pm – 5:00pm Location: Exhibit HallAbstract Number: 1029 – B0163

# # #

The Association for Research in Vision and Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include nearly 12,000 eye and vision researchers from over 75 countries. ARVO advances research worldwide into understanding the visual system and preventing, treating and curing its disorders. All abstracts accepted for presentation at the ARVO Annual Meeting represent previously unpublished data and conclusions. This research may be proprietary or may have been submitted for journal publication. Embargo policy: Journalists must seek approval from the presenter(s) before reporting data from paper or poster presentations. Press releases or stories on information presented at the ARVO Annual Meeting may not be released or published until the conclusion of the presentation.